35
EpiVario Inc. raises $500K in Regulation D offering in Philadelphia
Company raise · Raising · PHILADELPHIA, PA · Form D filed 2026-10-13
EpiVario Inc., a Delaware corporation in pharmaceuticals, is raising $500K under Regulation D exemption 6(b). The company has sold $185K to 9 investors so far with a $25K minimum investment.
other
Why now — by persona
- Executive & technical recruiting:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- B2B software & services sales:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Commercial banking / treasury:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- D&O and management-liability insurance:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Outsourced accounting / CFO:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
People on the filing
| Thomas Kim | Executive Officer, Director |
| Christopher Cashman | Director |
| Eric Schultenover | Director |
Signed by Thomas Kim, President and CEO.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.